LPS induces ALI by upregulating the NF-κB pathway (increasing the expression of pro-inflammatory cytokines), downregulating Nrf-2 (significantly altering oxidative stress parameters), and disrupting the alveolar epithelial–endothelial barrier, resulting in pulmonary edema and impaired lung function. Here, NFKB1 is linked to pulmonary edema.